Kassie D.
Paid to switch medications to stay on schedule — still stuck in review queue with dose due tomorrow
Paid to switch medications to stay on schedule, still stuck in review queue with dose due tomorrow. I submitted my intake on September 3, 2026 and paid $79.00 for the Semaglutide program (Invoice #SLUWSBDJ-0001). On September 7, I paid an additional $43.44 to switch to the Tirzepatide program (Invoice #SLUWSBDJ-0002), specifically to keep my treatment on schedule since my next dose is due September 8. Despite paying $122.44 total across both invoices, my order still shows "Processing," dose "pending medical review," and tracking "ships after medical review." On September 7 I contacted support by phone and by portal chat (agent Oliver, 3:13-3:25 PM). Both times I was told my chart had been "escalated" and to "allow some time," with no review timeframe given and no confirmation a provider would even look at my chart that day. I'm transferring ongoing care from my primary care provider, so this delay isn't a minor inconvenience, it's an actual gap in treatment. I've emailed support asking for a same-day review, guidance on the missed dose, a local pharmacy bridge option, and a credit for the disrupted period. My subscription renews monthly at $129, and right now I'm reconsidering whether to continue past this billing period. Updating this review based on how it's handled.
Response from EmbodySep 9, 2026
We’re sorry that you went through the added expense of switching programs specifically to avoid a gap in treatment, only to remain stuck in the medical review process. We also understand your concern about the additional payments and the uncertainty around what happens if your dose is delayed. We’d appreciate the opportunity to review your account, both invoices, the medication switch, and your previous communications with our team to understand what caused the delay and how we can address the concerns you raised. Please reach out to our support team with your account details so we can ensure this is properly reviewed and escalated. - Embody Team


